drugset / Trial / NCT01817465
A Study to Demonstrate the Efficacy and Safety of Motilitone®
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase IV , comparative study to evaluate the efficacy and safety of Motiltone® in treatment of the patients with functional dyspepsia. The study is conducted with following methods: multi-centers, double blind, randomization, parallel. The subjects will receive Motilitone® or/and Pantoline®.
Timeline
- Start
- 2012-08
- Primary completion
- 2014-03
- Completion
- 2014-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LUCORIDALINES | Unknown | 30 mg | — |
| Subject | LUCORIDALINES | Unknown | — | — |
| Comparator | Pantoprazole | Other / unclassified | 40 mg | — |
| Comparator | Pantoprazole | Other / unclassified | — | — |